Related Experiment Video

Updated: Jul 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.3K

Revisiting the minimum incubation period of Zaire ebolavirus

Aaron D Kofman1, Dana L Haberling1, Gisele Mbuyi2

  • 1Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA.

The Lancet. Infectious Diseases
|August 21, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Virus Propagation and Cell-Based Colorimetric Quantification
07:26

Virus Propagation and Cell-Based Colorimetric Quantification

Published on: April 7, 2023

889
Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

439

Related Experiment Videos

Last Updated: Jul 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.3K
Virus Propagation and Cell-Based Colorimetric Quantification
07:26

Virus Propagation and Cell-Based Colorimetric Quantification

Published on: April 7, 2023

889
Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

439

Related Concept Videos

Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...

Articles linked to this work by shared authors, journal, and citation graph.

Detection of new world hantaviruses by a broadly reactive rRT-PCR assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026

Longitudinal in vivo imaging reveals asynchronous, incomplete Nipah virus clearance with prolonged focal CNS involvement in IFNAR-/- mice.

Emerging microbes & infections·2026

Development and characterization of a recombinant Bundibugyo virus expressing a fluorescent reporter protein.

Emerging microbes & infections·2026

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses.

Vaccines·2026

A One Health investigation of a Crimean-Congo Hemorrhagic fever outbreak reveals high seropositivity in livestock in Lyantonde District, Uganda, 2024.

One health (Amsterdam, Netherlands)·2026

Potent in vitro antiviral activity of 4'-Fluorouridine against diverse orthohantaviruses including Andes virus.

Antiviral research·2026

Is a tiered classification framework needed for sexually transmitted infections?

The Lancet. Infectious diseases·2026

Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

The Lancet. Infectious diseases·2026

Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study.

The Lancet. Infectious diseases·2026

Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation study.

The Lancet. Infectious diseases·2026

Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications.

The Lancet. Infectious diseases·2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Infectious diseases·2026

Surgical Management and Diagnostic Incisional Biopsy of Palisaded Neutrophilic Granulomatous Dermatitis (PNGD): A Case Report.

Cureus·2026

Laparoscopy and Peritoneal Biopsy in the Diagnosis of Peritoneal Tuberculosis: A Case Report.

Clinical case reports·2026

Molecular mechanisms underlying drug resistance in protozoan parasites: emerging mechanisms and therapeutic perspectives.

Frontiers in parasitology·2026

Validation of serological markers of recent exposure to Plasmodium vivax in Cambodia: a longitudinal cohort and cross-sectional study.

The Lancet regional health. Western Pacific·2026

Deep learning-assisted malaria microscopy with sensitivity-aware threshold optimization.

Frontiers in medicine·2026

Deaths from infectious respiratory diseases in the Indigenous population: spatial and time series analysis, Minas Gerais, 2000-2023.

Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us